RECONCILE TABLET (CHEWABLE)

Country: Canada

Language: English

Source: Health Canada

Buy It Now

Active ingredient:

FLUOXETINE (FLUOXETINE HYDROCHLORIDE)

Available from:

PEGASUS LABORATORIES INC

Dosage:

16MG

Pharmaceutical form:

TABLET (CHEWABLE)

Composition:

FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 16MG

Administration route:

ORAL

Units in package:

30

Prescription type:

Prescription

Therapeutic group:

DOGS

Product summary:

Active ingredient group (AIG) number: 0116847006

Authorization status:

APPROVED

Authorization date:

2018-07-24

Patient Information leaflet

                                PRODUCT LABEL PROFILE
_Version 2 _
_–_
_ July 12, _
_2018_
BOTTLE LABEL ENGLISH - 16 mg
Dosage and Administration:
For use in dogs only. The
recommended dose of
Reconcile
chewable tablets is
1-2 mg/kg
administered once daily, in
conjunction with a behaviour
modification plan.
Storage:
Store at 20-25°C; excursions
permitted
between 15-30°C. Do not
remove
desiccant canister from the
bottle.
Completely close bottle between
uses.
Pegasus Laboratories, Inc.
8809 Ely Road
Pensacola, FL USA 32514
CA4205
DIN 02307960
PR
RECONCILE®
fluoxetine (as fluoxetine hydrochloride) chewable tablets
For Veterinary Use Only
A selective serotonin reuptake inhibitor
(SSRI)
for the treatment of canine
SEPARATION ANXIETY
in conjunction with a behaviour modification plan
16
mg
8.1-16.0 kg
Net: 30 Tablets
For complete product
information, see package insert.
Imported and distributed by:
_To be determined_
_ _
®
Pegasus Laboratories, Inc.
Warnings: Not for use in humans.
Keep out of reach of children.
Logo
LOT
EXP
PRODUCT LABEL PROFILE
_Version 2 _
_–_
_ July 12, _
_2018_
BOTTLE LABEL FRENCH - 16 mg
CA4205
PR
RECONCILE®
DIN 02307960
Veuillez consulter la notice
d
’
accompagnement pour obtenir
des renseignements complets sur
le produit.
fluoxétine (sous forme de chlorhydrate de fluoxétine)
comprimés à croquer
Pour usage veterinaire seulement
Un inhibiteur sélectif du recaptage de la sérotonine
(ISRS)
pour le traitement de
l'ANXIÉTÉ DE SÉPARATION
chez le chien en concomitance avec un
programme de modification du
comportement
16 mg
8,1 à 16 , 0 kg
Net : 30 comprimes
Logo
LOT
EXP
PRODUCT LABEL PROFILE
_Version 2 – July 12, 2018_
FRONT PANEL ENGLISH - CARTON 16 mg
CA4205
DIN 02307960
Dog Logo
PR
RECONCILE
®
FLUOXETINE (AS FLUOXETINE HYDROCHLORIDE) CHEWABLE TABLETS
For Veterinary Use Only
A selective serotonin reuptake inhibitor (SSRI) for
the treatment of canine SEPARATION
ANXIETY
in conjunction with a behaviour modification plan
16 mg
8.1-16.0 kg
Net: 30 Tablets, 16 mg each
Logo
WARNINGS: NOT FOR USE IN HUMANS. KEEP
OUT 
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet French 24-07-2018

Search alerts related to this product